MedTrace Logo

The Short-term Efficacy of Gastrodia and Uncaria Drink in Treating Hypertension

NCT02156024 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2014-06-06

No results posted yet for this study

Summary

The purpose of this study is

1. To determine whether the Gastrodia and Uncaria Drink is effective in the treatment of masked hypertensive patients below 70 years.
2. To find out the suitable groups for the Gastrodia and Uncaria Drink treatment.

Conditions

  • Masked Hypertension

Interventions

DRUG

Gastrodia and Uncaria Drink

Gastrodia and Uncaria Drink, 1 dose at a time, twice a day, duration: 4 weeks

Sponsors & Collaborators

  • Shanghai Institute of Hypertension

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2015-03-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02156024 on ClinicalTrials.gov